How to develop better screens for anti-cancer therapies?
The clinical efficacy of chemotherapy relies in part on its ability to potentiate anti-tumor immune responses. Recent work shows that several chemotherapeutic drugs induce intra-tumoral expression of lymphocyte-attracting chemokines, leading to clinical responses. Here, we argue that such knowledge should be used to screen for novel anti-tumor treatments.
Singapore Immunology Network; BMSI; A-STAR; Singapore.
Michelle
M
Hong
Jean-Pierre
JP
Abastado